Cocaine: A catalyst for human immunodeficiency virus-associated dementia

American Journal of Infectious Diseases

Volumn 4, Issue 2, 2008, Pages 131-139

  Dhillon, Navneet K ^a   Gadgil, Milind ^a   Rahardja, Andy ^a   Callen, Shannon ^a   Sidelnik, Alex ^a   Renfrow, Duncan ^a   Moradi, Amanda ^a   Dhillon, Sukhbir ^a   Kenjale, Himanshu ^a   Kumar, Anil ^b   Buch, Shilpa J ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Blood brain barrier; Cocaine; HIV; Transcription factors

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; COCAINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR EGR 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CALCIUM MOBILIZATION; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; COCAINE DEPENDENCE; CYTOTOXICITY; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LEUKOCYTE; MACROPHAGE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RISK FACTOR; UPREGULATION; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 41149126601     PISSN: 15536203     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajidsp.2008.131.139     Document Type: Article

References (97)

1. Fiala, M, XH Gan, L Zhang, SD House, T Newton, MC Graves, P Shapshak, M Stins, KS Kim, M Witte, SL Chang, 1998. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? Adv.Exp.Med.Biol., 437:199-205.
2. Larrat, EP, S Zierler, 1993. Entangled, epidemics: cocaine use and HIV disease. J Psychoactive Drugs, 25:207-21.
3. Webber, MP, EE Schoenbaum, MN Gourevitch, D Buono, RS Klein, 1999. A prospective study of HIV disease progression in female and male drug users. AIDS, 13:257-62.
4. Clarke, JN, JA Lake, CJ Burrell, SL Wesselingh, PR Gorry, P Li, 2006. Novel pathway of human immunodeficiency virus type 1 uptake and release in astrocytes. Virology, 348:141-55.
5. Brack-Werner, R, 1999. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS, 13:1-22.
6. Canki, M, JN Thai, W Chao, A Ghorpade, MJ Potash, DJ Volsky, 2001. Highly productive infection with pseudotyped human immunodeficiency vinis type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes. J. Virol., 75:7925-33.
7. Glass, JD, H Fedor, SL Wesselingh, JC McArthur, 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol JID - 7707449, 38.755-62.
8. Glass, JD, SL Wesselingh, OA Selnes, JC McArthur, 1993. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology, 43;2230-7.
9. Tyor, WR, SL Wesselingh, JW Griffin, JC McArthur, DE Griffin, 1995. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J.Acquir.Immune.Defic.Syndr.Hum.Retrovirol., 9:379-88.
10. Gray, F, H Adle-Biassette, F Brion, T Ereau, MI le, V Levy, G Corcket, 2000. Neuronal apoptosis in human immunodeficiency virus infection. J.Neurovirol., 6 Suppl 1:S38-S43.
11. Klein, TW, K Matsui, CA Newton, J Young, RE Widen, H Friedman, 1993. Cocaine suppresses proliferation of phytohemagglutinin-activated human peripheral blood T-cells. Int.J Immunopharmacol., 15:77-86.
12. Mao, JT, M Huang, J Wang, S Sharma, DP Tashkin, SM Dubinett, 1996. Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production. Cell Immunol., 172:217-23.
13. Baldwin, GC, DP Tashkin, DM Buckley, AN Park, SM Dubinett, MD Roth, 1997. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am.J Respir.Crit Care Med., 156:1606-13.
14. Eisenstein, TK, ME Hilburger, 1998. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmunol., 83:36-44.
15. Friedman, H, C Newton, TW Klein, 2003. Microbial infections, immunomodulation, and drugs of abuse. Clin.Microbiol.Rev., 16:209-19.
16. Bagastra, O, RJ Pomerantz, 1993. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect.Dis., 168:1157-64.
17. Peterson, PK, BM Sharp, G Gekker, PS Portoghese, K Sannerud, HH Balfour, 1990. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS, 4:869-73.
18. Nair, MPN, S Mahajan, J Hou, AM Sweet, SA Schwartz, 2000. The stress hormone, cortisol, synergizes with HIV-1 gp-120 to induce apoptosis of normal human peripheral blood mononuclear cells. Cell Mol.Biol.(Noisy.-le-grand), 46:1227-38.
19. Roth, MD, DP Tashkin, R Choi, BD Jamieson, JA Zack, GC Baldwin, 2002. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect.Dis., 185:701-5.
20. Steele. AD. EE Henderson. TJ Rogers. 2003. Muopioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology, 309:99-107.
21. Anthony, JC, D Vlahov, KE Nelson, S Cohn, J Astemborski, L Solomon, 1991. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol., 134:1175-89.
22. Baldwin, GC, MD Roth, DP Tashkin, 1998. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol., 83:133-8.
23. Chaisson, RE, P Bacchetti, D Osmond, B Brodie, MA Sande, AR Moss, 1989. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA, 261:561-5.
24. Doherty, MC, RS Garfein, E Monterroso, D Brown, D Vlahov, 2000. Correlates of HIV infection among young adult short-term injection drug users. AIDS, 14:717-26.
25. Chiasson, MA, RL Stoneburner, DS Hildebrandt, WE Ewing, EE Telzak, HW Jaffe, 1991. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack), AIDS, 5:1121-6.
26. Peterson, PK, G Gekker, CC Chao, R Schut, TW Molitor, HH Balfour, 1991. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. J Immunol., 146:81-4.
27. Peterson, PK, G Gekker, CC Chao, R Schut, J Verhoef, CK Edelman, A Erice, HH Balfour, Jr., 1992. Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures. J Immunol., 149:676-80.
28. Rosenberg, ZF, AS Fauci, 1989. Induction of expression of HIV in latently or chronically infected cells. AIDS Res Hum Retroviruses, 5:1-4.
29. Levy, JA, 1989. Human immunodeficiency viruses and the pathogenesis of AIDS. Jama, 261:2997-3006.
30. Gallo, RC, 1990. Mechanism of disease induction by HIV. J Acquir Immune Defic Syndr, 3:380-9.
31. Skolnik, PR, BR Kosloff, MS Hirsch, 1988. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J Infect Dis, 157:508-14.
32. Clouse, KA, PB Robbins, B Fernie, JM Ostrove, AS Fauci, 1989. Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression. J Immunol, 143:470-5.
33. Drew, WL, 1988. Cytomegalovirus infection in patients with AIDS. J Infect Dis, 158:449-56.
34. Jacobson, MA, J Mills, 1988. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med, 108:585-94.
35. Schoolev. RT. 1990. Cytomegalovirus in the setting of infection with human immunodeficiency virus. Rev Infect Dis, 12 Suppl 7:S811-9.
36. Peterson, PK, G Gekker, R Schut, S Hu, HH Balfour, Jr., CC Chao, 1993. Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. Adv.Exp.Med.Biol., 335:181-8.
37. Reynolds, JL, SD Mahajan, B Bindukumar, D Sykes, SA Schwartz, MP Nair, 2006. Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res, 1123:226-36.
38. Gekker, G, S Hu, MP Wentland, JM Bidlack, JR Lokensgard, PK Peterson, 2004. Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells. J Pharmacol Exp Ther, 309:600-6.
39. Gekker, G, S Hu, WS Sheng, RB Rock, JR Lokensgard, PK Peterson, 2006. Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. Int Immunopharmacol, 6:1029-33.
40. Minagar, A, P Shapshak, R Fujimura, R Ownby, M Heyes, C Eisdorfer, 2002. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci, 202:13-23.
41. Gonzalez-Scarano, F, J Martin-Garcia, 2005. The neuropathogenesis of AIDS. Nat Rev Immunol, 5:69-81.
42. Conant, K, C Tomatore, W Atwood, K Meyers, R Traub, EO Major, 1994. In vivo and in vitro infection of the astrocyte by HIV-1. Adv.Neuroimmunol., 4:287-9.
43. Dong, Y, EN Benveniste, 2001. Immune function of astrocytes. Glia, 36:180-90.
44. Hansson, E, L Ronnback, 2003. Glial neuronal signaling in the central nervous system. Faseb J, 17:341-8.
45. Kumar, M, AM Kumar, D Waldrop, MH Antoni, N Schneiderman, C Eisdorfer, 2002. The HPA axis in HIV-1 infection. J Acquir Immune Defic Syndr, 31 Suppl 2:S89-93.
46. Roth, MD, KM Whittaker, R Choi, DP Tashkin, GC Baldwin, 2005. Cocaine and sigma-1, receptors modulate HIV infection, chemokine receptors, and the HPA axis in the, huPBL-SCID model. J.Leukoc.Biol., 78:1198-203.
47. Fattore, L, MC Puddu, S Picciau, A Cappai, W Fratta, GP Serra, S Spiga, 2002. Astroglial in vivo response to cocaine in mouse dentate gyrus: a quantitative and qualitative analysis by confocal microscopy. Neuroscience, 110:1-6.
48. Mao, JT, LX Zhu, S Sharma, K Chen, M Huang, SJ Santiago, J Gulsurd, DP Tashkin, SM Dubinett, 1997. Cocaine inhibits human endothelial cell IL-8 production: the role of transforming growth factor-beta. Cell Immunol, 181:38-43.
49. Wang, Y, DS Huang, RR Watson, 1994. In vivo and in vitro cocaine modillation on production of cytokines in C57BL/6 mice. Life Sci., 54:401-11.
50. Watzl, B, G Chen, P Scuderi, S Pirozhkov, RR Watson, 1992. Cocaine-induced suppression of interferon-gamma secretion in leukocytes from young and old C57BL/6 mice. Int J Immunopharmacol, 14:1125-31.
51. Stanulis, ED, SD Jordan, JA Rosecrans, MP Holsapple, 1997. Disruption of Th1/Th2 cytokine balance by cocaine is mediated by corticosterone. Immunopharmacology, 37:25-33.
52. Gardner, B, LX Zhu, MD Roth, DP Tashkin, SM Dubinett, S Sharma, 2004. Cocaine modulates cytokine and enhances tumor growth through sigma receptors. J Neuroimmunol., 147:95-8.
53. Berkeley, MB, S Daussia, MC Hernandez, BM Bayer, 1994. In vitro effects of cocaine, lidocaine and monoamine uptake inhibitors on lymphocyte proliferative responses. Immunopharmacol Immunotoxicol, 16:165-78.
54. Delafuente, JC, CL DeVane, 1991. Immunologic effects of cocaine and related alkaloids. Immunopharmacol Immunotoxicol, 13:11-23.
55. Klein, TW, CA Newton, H Friedman, 1988. Suppression of human and mouse lymphocyte proliferation by cocaine. Adv Biochem Psychopharmacol, 44:139-43.
56. Matsui, K, H Friedman, TW Klein, 1993. Molecular mechanisms associated with cocaine-induced modulation of human T lymphocytes proliferation. Adv Exp Med Biol, 335:127-34.
57. Matsui, K, H Friedman, TW Klein, 1992. Cocaine augments proliferation of human peripheral blood T-lymphocytes activated with anti-CD3 antibody. Int J Immunopharmacol, 14:1213-20.
58. New, DR, M Ma, LG Epstein, A Nath, HA Gelbard, 1997. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J.Neurovirol., 3:168-73.
59. Bansal, AK, CF Mactutus, A Nath, W Maragos, KF Hauser, RM, Booze 2000. Neurotoxicity of HIV-1 proteins gp120 Tat in the rat striatum. Brain Res. 879:42-9.
60. Gurwell, JA, A Nath, Q Sun, J Zhang, KM Martin, Y Chen, KF Hauser, 2001. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience, 102:555-63.
61. Savio, T, G Levi, 1993. Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J.Neurosci.Res., 34:265-72.
62. Lipton, SA, NJ Sucher, PK Kaiser, EB Dreyer, 1991. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron, 7:111-8.
63. Kaul, M, GA Garden, SA Lipton, 2001. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature, 410:988-94.
64. Kaul, M, SA Lipton, 1999. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc.Natl.Acad.Sci.U.S.A, 96:8212-6.
65. Turchan, J, C Anderson, KF Hauser, Q Sun, J Zhang, Y Liu, PM Wise, I Kruman, W Maragos, MP Mattson, R Booze, A Nath, 2001. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC.Neurosci., 2:3.
66. Nath, A, KF Hauser, V Wojna, RM Booze, W Maragos, M Prendergast, W Cass, JT Turchan, 2002. Molecular basis for interactions of HIV and drugs of abuse. J Acquir.Immune Defic.Syndr., 31 Suppl 2:S62-S9.
67. Maragos, WF, KL Young, JT Turchan, M Guseva, JR Pauly, A Nath, WA Cass, 2002. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem, 83:955-63.
68. Nath, A, C Anderson, M Jones, W Maragos, R Booze, C Mactutus, J Bell, KF Hauser, M Mattson, 2000. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol., 14:222-7.
69. Koutsilieri, E, ME Gotz, S Sopper, U Sauer, M Demuth, V ter Meulen, P Riederer, 1997. Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro. J Neurovirol, 3:342-9.
70. Aksenov, MY, MV Aksenova, A Nath, PD Ray, CF Mactutus, RM Booze, 2006. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology, 27:217-28.
71. Lee, YW, B Hennig, M Fiala, KS Kim, M Toborek, 2001. Cocaine activates redox-regulated transcription factors and induces TNF-alpha expression in human brain endothelial cells. Brain Res., 920:125-33.
72. Schreck, R, K Albermann, PA Baeuerle, 1992. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun, 17:221-37.
73. Malaplate-Armand, C, P Becuwe, L Ferrari, C Masson, M Dauca, S Visvikis, H Lambert, AM Batt, 2005. Effect of acute and chronic psychostimulant drugs, on redox status, AP-1 activation and pro-enkephatin mRNA in the human astrocyte-like U373 MG cells. Neuropharmacology, 48:673- 84
74. Couceyro, P, KM Pollock, K Drews, J Douglass, 1994. Cocaine differentially regulates activator protein-1 mRNA levels and DNA-binding complexes in the rat striatum and cerebellum. Mol Pharmacol. 46:667-76
75. Pennypacker, K, 1998. AP-1 transcription factors: short- and long-term modulators of gene expression in the brain. Int Rev Neurobiol, 42:169-97.
76. Hope, B, B Kosofsky, SE Hyman, EJ Nestler, 1992. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc.Natl.Acad.Sci.U.S.A, 89:5764-8.
77. Bhat, RV, JM Baraban, 1993. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J.Pharmacol.Exp.Ther., 267:496-505.
78. Moratalla, R, HA Robertson, AM Graybiel, 1992. Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J.Neurosci., 12:2609-22.
79. Drago, J, CR Gerfen, H Westphal, H Steiner, 1996. D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience, 74:813-23.
80. Mailleux, P, F Zhang, JJ Vanderhaeghen, 1992. The dopamine D1 receptor antagonist SCH-23390 decreases the mRNA levels of the transcription factor zif268 (krox-24) in adult rat intact striatuman in situ hybridization study. Neurosci Lett, 147:182-4.
81. Thiriet, N, D Aunis, J Zwiller, 2002. The nitric oxide releasing agent sodium nitroprusside modulates cocaine-induced immediate early gene expression in rat brain. Ann N Y Acad Sci, 965:47-54.
82. Dhillon, N, R, Williams, F. Peng et al., 2007. Cocaine-mediated Enhancement of Virus Replication in Macrophages: Implications for HIV-Dementia. J Neurovirology, In press.
83. Burger, DM, CA Boucher, PL, Meenhorst, CL Kraayeveld, P Portegies, JW Mulder, RM, Hoetelmans, JH Beijnen, 1997. HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier. Antivir Ther, 2:113-7.
84. Nottet, HS, Y Persidsky, VG Sasseville, AN Nukuna, P Bock, QH Zhai, LR Sharer, RD McComb, S Swindells, C Soderland, HE Gendelman, 1996. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol, 156:1284-95.
85. Dallasta, LM, LA Pisarov, JE Esplen, JV Werley, AV Moses, JA Nelson, CL Achim, 1999. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol, 155:1915-27.
86. Avison, MJ, A Nath, R Greene-Avison, FA Schmitt, RA Bales, A Ethisham, RN Greenberg, JR Berger, 2004. Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J Neurovirol, 10:223-32.
87. Fiala, M, C Gujuluva, O Berger, M Bukrinsky, KS Kim, MC Graves, 2001. Chemokine receptors on brain endothelia - keys to HIV-1 neuroinvasion? Adv.Exp.Med.Biol., 493:35-40.
88. Gan, X, L Zhang, O Berger, MF Stins, D Way, DD Taub, SL Chang, KS Kim, SD House, M Weinand, M Witte, MC Graves, M Fiala, 1999. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin.Immunol., 91:68-76.
89. Chang, SL, J Bersig, B Felix, M Fiala, SD House, 2000. Chronic cocaine alters hemodynamics and leukocyte-endothelial interactions in rat mesenteric venules. Life Sci., 66:2357-69.
90. Nair, MP, SD Mahajan, SA Schwartz, J Reynolds, R Whitney, Z Bernstein, RP Chawda, D Sykes, R Hewitt, CB Hsiao, 2005. Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients. J Immunol, 174:6617-26.
91. Fiala, M, AJ Eshleman, J Cashman, J Lin, AS Lossinsky, V Suarez, W Yang, J Zhang, W Popik, E Singer, F Chiappelli, E Carro, M Weinand, M Witte, J Arthos, 2005. Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J Neurovirol., 11:281-91.
92. Dhillon, N, R. Williams, F. Peng, Yi-jou Tsai, S. Dhillon, B. Nicolay, M. Gadgil, A. Kumar and S. Buch., In press. Cocaine-mediated Enhancement of Virus Replication in Macrophages: Implications for HIV-Dementia. J Neurovirology.
93. Buch, S, D Pinson, CL King, R Raghavan, Y Hou, Z Li, I Adany, A Hicks, F Villinger, A Kumar, O Narayan, 2001. Inhibitory and enhancing effects of IFTN-gamma and IL-4 on SHIV(KU) replication in rhesus macaque macrophages: correlation between Th2 cytokines and productive infection in tissue macrophages during late-stage infection. Cytokine JID - 9005353, 13:295-304.
94. Buch, SJ, F Villinger, D Pinson, Y Hou, I Adany, Z Li, R Dalal, R Raghavan, A Kumar, O Narayan, 2002. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease. Virology JID - 0110674, 295:54-62.
95. Dhillon, NK, Y Sui, R Potula, S Dhillon, I Adany, Z Li. F Villinger D Pinson. O Naravan. S Buch. 2005. Inhibition of pathogenic SHIV replication in macaques treated with antisense DNA of interleukin-4. Blood, 105:3094-9.
96. Hicks, A, R Potula, YJ Sui, F Villinger, D Pinson, I Adany, Z Li, C Long, P Cheney, J Marcario, F Novembre, N Mueller, A Kumar, E Major, O Narayan, S Buch, 2002. Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages. Am.J.Pathol., 161:813-22.
97. Yi, Y, W Chen, I Frank, J Cutilli, A Singh, L Starr-Spires, J Sulcove, DL Kolson, RG Collman, 2003. An unusual syncytia-inducing human immunodeficiency virus type 1 primary isolate from the central nervous system that is restricted to CXCR4, replicates efficiently in macrophages, and induces neuronal apoptosis. J Neurovirol., 9:432-41.